That does not necessarily mean it is proven to rebuild injured tendons in people, but it does explain why interest in the peptide remains high
Thus, given the proposed importance of neuroendocrine cells in asthma and COPD, it is possible that an undiscovered yet important role of neuroendocrine cells, and by extension bombesins, in CF exists
A reader who wants to evaluate the underlying papers can search PubMed for "GHK-Cu", "Thymosin beta 4 wound", "BPC-157 tendon" and "BPC-157 angiogenesis" to find the canonical entry points
Common Factors Affecting Peptide Dosing Protocols When a clinician writes a peptide plan, they look at a lot of things: Patient goals and symptoms Medical and injury history Contraindications and current meds ADT: Previous exposure to peptides Method of administration Product concentration Time frame of treatment The monitoring plan Non-clinicians shouldn't make these choices, and don't just copy what other clinics do without review by your medical director
It is used most frequently for kidney disease and sometimes for lung and heart disease
